A related issue showing the importance of clinico-pathological correlation is the occurrence of JAK2 mutations in individuals without clinical or laboratory evidence of an MPN, which in this setting is considered a CHIP mutation [157]. Here, JAK2 is linked to myeloproliferative neoplasm.